dacarbazine

Our data suggest that all mentioned treatments significantly reduce cell migration by downregulating MMP-2 and MMP-9 and decrease clonogenicity by downregulating SOX2 and OCT4 in SK-MEL-3 cells, with these effects being more evident after combination treatment. In conclusion, our findings highlight the potential of PDT pre-treatment to enhance DTIC sensitivity in SK-MEL-3 cells and suggest that the combination therapy is a promising strategy for further research in melanoma treatment.

In the poorly immunogenic B16-F10 melanoma model, combining circular CpG ODNs with dacarbazine (DTIC) chemotherapy produced markedly stronger and more sustained antitumor efficacy, with enhanced tumor regression and improved survival, compared to linear CpG ODN/DTIC combinations. Our findings establish circular CpG ODNs as a promising platform for cancer immunotherapy, offering improved long-term stability and potent immunomodulatory capacity, particularly in combination with chemotherapy.

P=N/A, N=118, Completed, Memorial Sloan Kettering Cancer Center | Active, not recruiting --> Completed | Trial completion date: May 2027 --> Jun 2026 | Trial primary completion date: May 2027 --> Jun 2026

P=N/A, N=118, Active, not recruiting, Memorial Sloan Kettering Cancer Center | Trial completion date: May 2026 --> May 2027 | Trial primary completion date: May 2026 --> May 2027

P2/3, N=370, Not yet recruiting, Polska Grupa Badawcza Chloniakow

Thus, Zerumbone has potential as a practical approach to battle melanoma, either as a standalone treatment or in conjunction with Dacarbazine. However, more pre-clinical and clinical studies are required to investigate its efficacy.

P1, N=140, Completed, AstraZeneca | Active, not recruiting --> Completed

P2, N=49, Completed, Northwestern University | Unknown status --> Completed

In the longest survival follow-up of a randomized trial in metastatic uveal melanoma, tebentafusp continues to provide long-term survival benefit in previously untreated HLA-A*02:01-positive patients.

Postpartum positron emission tomography/computed tomography demonstrated extensive supradiaphragmatic disease, and chemotherapy with doxorubicin, bleomycin, vinblastine, and dacarbazine was promptly initiated. The patient showed a favorable clinical and metabolic response, and the neonate demonstrated normal early postnatal development. This case highlights the importance of early recognition and multidisciplinary management of superior vena cava syndrome in pregnancy and raises the hypothesis that pregnancy-associated immunologic changes, including interleukin-6-mediated pathways, may contribute to accelerated disease progression.

P2, N=24, Active, not recruiting, University of Virginia | Recruiting --> Active, not recruiting | N=44 --> 24

This study elucidates alterations in adhesion molecule expression in melanoma cells acquiring resistance to dacarbazine (DTIC) and entering the G0 state...These findings suggest that PLXNA2 down-regulation in DTIC-treated cancer cells promotes their apoptosis. Therefore, targeting focal adhesion molecules during chemotherapy can increase the sensitivity of tumor cells to anticancer treatment.